Lonafarnib and Simvastatin: Interaction Details

Brand names
Lonafarnib
Zokinvy
Simvastatin
FlolipidZocor
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Lonafarnib With Simvastatin

What can happen when they are taken together (rated Contraindicated)

Increased simvastatin exposure and an increased risk of or

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Lonafarnib inhibits and simvastatin is a CYP3A , so using the two together is . The combination may raise simvastatin exposure, which in turn may heighten the risk of simvastatin-related adverse reactions such as myopathy or rhabdomyolysis.

A clinical study in healthy subjects gave a single oral 3 mg dose of midazolam (also a CYP3A substrate) together with 100 mg of lonafarnib orally twice daily for 5 days. Under these conditions, midazolam rose by 180% and rose by 639%.1

The Lonafarnib and Simvastatin Interaction, Explained

These two medicines should not be taken together. Lonafarnib slows down an enzyme in your liver () that normally clears simvastatin from your body. With less , more simvastatin can build up in your blood. Higher simvastatin levels raise the chance of muscle problems, ranging from aches and weakness to a rare but serious muscle breakdown called that can harm the kidneys.

This is a prediction based on how the drugs work. Lonafarnib was shown to raise levels of another CYP3A-cleared drug (midazolam) several-fold. Please don't stop or change anything on your own. Tell your pharmacist or doctor about both medicines so your care team can choose a safer way to manage your cholesterol.

(theoretical evidence). Lonafarnib is a strong ; simvastatin is a with extensive , so is expected to markedly raise simvastatin exposure (, ) and the risk of and .

  • Supporting data: with lonafarnib 100 mg BID for 5 days, midazolam Cmax rose 180% and AUC 639%.
  • No direct simvastatin study; onset unspecified.
  • Management: avoid . Consider a less dependent on CYP3A (e.g., rosuvastatin, pravastatin), chosen and dosed per prescriber judgment.
  • Counsel patients to report unexplained muscle pain, weakness, or dark urine; CK monitoring per clinical judgment.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Lonafarnib and Simvastatin Interact

The likely mechanism

of -mediated of simvastatin

In short: Lonafarnib slows CYP3A, an enzyme that breaks down simvastatin, so simvastatin can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Lonafarnib and Simvastatin Interaction

The documented management is to avoid using these two medicines together. Your care team typically reviews your cholesterol treatment and may consider a different option that is less affected by this enzyme. Any change should come from your prescriber.

  • Do not stop or change either medicine on your own.
  • Make sure your pharmacist and prescribers know you take both lonafarnib and simvastatin.
  • Report unexplained muscle pain, tenderness, weakness, or dark urine right away.

Your care team can tailor your treatment and may monitor you more closely.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Lonafarnib or Simvastatin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: ZOKINVY oral capsules, lonafarnib oral capsules

    In a clinical study in healthy subjects, a single oral 3 mg dose of midazolam (a ) was given together with multiple oral doses of lonafarnib 100 mg twice daily for 5 days. Under these conditions, midazolam rose by 180% and rose by 639%.1

Lonafarnib and Simvastatin: Common Questions

How serious is the Lonafarnib and Simvastatin interaction?

It is rated . These should generally not be used together.

How is the Lonafarnib and Simvastatin interaction managed?

The documented management is to avoid using these two medicines together. Your care team typically reviews your cholesterol treatment and may consider a different option that is less affected by this enzyme. Any change should come from your prescriber. Do not stop or change either medicine on your own. Make sure your pharmacist and prescribers know you take both lonafarnib and simvastatin. Report… Management is individual — always follow your own care team's guidance.

Does taking Lonafarnib and Simvastatin at different times of day help?

No. Taking them at different times of day does not prevent this one. Lonafarnib slows , an enzyme that breaks down simvastatin, so simvastatin can build up in the body. That change lasts while lonafarnib is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Lonafarnib and Simvastatin Interaction

Ask in your own words about taking Lonafarnib and Simvastatin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: ZOKINVY(TM) oral capsules, lonafarnib oral capsules. Eiger BioPharmaceuticals Inc (per FDA), Palo Alto, CA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Lonafarnib and Simvastatin

Also serious with Lonafarnib

Also serious with Simvastatin

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Lonafarnib

With Simvastatin

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.